Brighton, MA, United States of America

Ed O'Connell


 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ed O'Connell: Innovator in Pharmaceutical Technologies

Introduction

Ed O'Connell is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of pharmaceutical technologies, particularly in the development of innovative methods for drug delivery systems. With a total of 3 patents to his name, O'Connell's work has the potential to impact the medical industry significantly.

Latest Patents

One of O'Connell's latest patents is titled "Protein microspheres retaining pharmacokinetic and pharmacodynamic properties." This patent describes compositions and methods for creating small particles of an active agent. The process involves dissolving the active agent in a solvent that enhances phase separation, leading to the formation of small spherical particles that are injectable through fine bore needles. These particles maintain the pharmacokinetic and pharmacodynamic properties of the active agent, making them particularly useful for higher molecular weight proteins such as antibodies.

Another significant patent is focused on "Methods of processing compositions containing microparticles." This method outlines a process for handling multi-phasic dispersions, which includes exposing the dispersion to a non-solvent to create a suspension with solid microparticles. This innovative approach allows for the removal of non-volatile materials while retaining the essential microparticles.

Career Highlights

Throughout his career, Ed O'Connell has worked with prominent companies in the pharmaceutical sector, including Baxter International Inc. and Baxter Healthcare SA. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

O'Connell has collaborated with several professionals in his field, including Larry Richard Brown and Mark X Yang. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical technologies.

Conclusion

Ed O'Connell's contributions to the field of pharmaceutical innovations are noteworthy. His patents reflect a commitment to advancing drug delivery systems, which could have a lasting impact on medical treatments. O'Connell's work exemplifies the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…